Literature DB >> 16353973

Etoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluation.

L Harivardhan Reddy1, R S R Murthy.   

Abstract

The aim of the study was to prepare etoposide-loaded nanoparticles with glyceride lipids and then characterize and evaluate the in vitro steric stability and drug release characteristics and stability. The nanoparticles were prepared by melt emulsification and homogenization followed by spray drying of nanodispersion. Spray drying created powder nanoparticles with excellent redispersibility and a minimal increase in particle size (20-40 nm). Experimental variables, such as homogenization pressure, number of homogenization cycles, and surfactant concentration, showed a profound influence on the particle size and distribution. Spray drying of Poloxamer 407-stabilized nanodispersion lead to the formation of matrix-like structures surrounding the nanoparticles, resulting in particle growth. The in vitro steric stability test revealed that the lipid nanoparticles stabilized by sodium tauroglycocholate exhibit excellent steric stability compared with Poloxamer 407. All 3 glyceride nanoparticle formulations exhibited sustained release characteristics, and the release pattern followed the Higuchi equation. The spray-dried lipid nanoparticles stored in black polypropylene containers exhibited excellent long-term stability at 25 degrees C and room light conditions. Such stable lipid nanoparticles with in vitro steric stability can be a beneficial delivery system for intravenous administration as long circulating carriers for controlled and targeted drug delivery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16353973      PMCID: PMC2750527          DOI: 10.1208/pt060224

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  21 in total

1.  Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization.

Authors:  C Schwarz; W Mehnert
Journal:  J Microencapsul       Date:  1999 Mar-Apr       Impact factor: 3.142

2.  Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase.

Authors:  C Freitas; R H Müller
Journal:  Eur J Pharm Biopharm       Date:  1999-03       Impact factor: 5.571

3.  Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant.

Authors:  R H Müller; D Rühl; S Runge; K Schulze-Forster; W Mehnert
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

4.  Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain.

Authors:  S C Yang; L F Lu; Y Cai; J B Zhu; B W Liang; C Z Yang
Journal:  J Control Release       Date:  1999-06-02       Impact factor: 9.776

5.  Optimization of spray-dried and -congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy.

Authors:  T Eldem; P Speiser; A Hincal
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

6.  Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating.

Authors:  S M Moghimi; C J Porter; I S Muir; L Illum; S S Davis
Journal:  Biochem Biophys Res Commun       Date:  1991-06-14       Impact factor: 3.575

7.  Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.

Authors:  R H Müller; S Maassen; H Weyhers; W Mehnert
Journal:  J Drug Target       Date:  1996       Impact factor: 5.121

8.  Spray-drying of solid lipid nanoparticles (SLN TM).

Authors:  C Freitas; R H Müllerä
Journal:  Eur J Pharm Biopharm       Date:  1998-09       Impact factor: 5.571

9.  Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.

Authors:  A zur Mühlen; C Schwarz; W Mehnert
Journal:  Eur J Pharm Biopharm       Date:  1998-03       Impact factor: 5.571

10.  Preparation of sterically stabilized human serum albumin nanospheres using a novel Dextranox-MPEG crosslinking agent.

Authors:  W Lin; A G Coombes; M C Garnett; M C Davies; E Schacht; S S Davis; L Illum
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

View more
  17 in total

1.  Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 2(3) full-factorial design.

Authors:  Mayank Shah; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2010-03-23       Impact factor: 3.246

2.  Degradation kinetics and mechanism of RH1, a new anti-tumor agent: a technical note.

Authors:  Neera Jain; Stephen G Machatha; S Esmail Tabibi; Samuel H Yalkowsky
Journal:  AAPS PharmSciTech       Date:  2007-03-02       Impact factor: 3.246

3.  Tumoricidal effects of etoposide incorporated into solid lipid nanoparticles after intraperitoneal administration in Dalton's lymphoma bearing mice.

Authors:  Lakkireddy Harivardhan Reddy; Jawahar Singh Adhikari; Bilikere Srinirasa Rao Dwarakanath; Rakesh Kumar Sharma; Rayasa Ramachandra Murthy
Journal:  AAPS J       Date:  2006-04-14       Impact factor: 4.009

4.  Effect of squalane on mebendazole-loaded Compritol® nanoparticles.

Authors:  Richard A Graves; Grace A Ledet; Cedric A Nation; Yashoda V Pramar; Levon A Bostanian; Tarun K Mandal
Journal:  J Biomater Sci Polym Ed       Date:  2015-07-09       Impact factor: 3.517

5.  Etoposide Amorphous Nanopowder for Improved Oral Bioavailability: Formulation Development, Optimization, in vitro and in vivo Evaluation.

Authors:  Yue Wang; Shuhang Wang; Yingju Xu; Ping Wang; Sukai Li; Lu Liu; Mengyan Liu; Xiangqun Jin
Journal:  Int J Nanomedicine       Date:  2020-10-08

6.  Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery.

Authors:  Mangesh R Bhalekar; Varsha Pokharkar; Ashwini Madgulkar; Nilam Patil; Nilkanth Patil
Journal:  AAPS PharmSciTech       Date:  2009-03-18       Impact factor: 3.246

7.  Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation.

Authors:  Ketan Hippalgaonkar; Goutham R Adelli; Kanchan Hippalgaonkar; Michael A Repka; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-19       Impact factor: 2.671

8.  Diazepam-loaded solid lipid nanoparticles: design and characterization.

Authors:  Ghada Abdelbary; Rania H Fahmy
Journal:  AAPS PharmSciTech       Date:  2009-03-10       Impact factor: 3.246

Review 9.  Pharmaceutical and pharmacological approaches for bioavailability enhancement of etoposide.

Authors:  Ishtiyaq Ahmad Najar; Rakesh Kamal Johri
Journal:  J Biosci       Date:  2014-03       Impact factor: 1.826

10.  Enhanced efficacy of local etoposide delivery by poly(ether-anhydride) particles against small cell lung cancer in vivo.

Authors:  Benjamin C Tang; Jie Fu; D Neil Watkins; Justin Hanes
Journal:  Biomaterials       Date:  2009-09-30       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.